MyFinsight
Home
Blog
About
Cash and cash
equivalents
$43,181,002
(45.11%↑ Y/Y)
Prepaids and other
current assets
$3,876,735
(5.62%↑ Y/Y)
Total current assets
$47,057,737
(40.77%↑ Y/Y)
Other assets
$244,727
Fixed assets, net
$5,614
(-77.46%↓ Y/Y)
Total assets
$47,308,078
(41.42%↑ Y/Y)
Total liabilities and
stockholders' equity
$47,308,078
(41.42%↑ Y/Y)
Total stockholders'
equity
$43,276,011
(52.86%↑ Y/Y)
Total liabilities
$4,032,067
(-21.59%↓ Y/Y)
Accumulated deficit
-$75,808,527
(-40.03%↓ Y/Y)
Additional paid-in capital
$119,082,192
(44.43%↑ Y/Y)
Total current
liabilities
$3,512,431
(-21.97%↓ Y/Y)
Deferred collaboration
revenue
$519,636
(-18.95%↓ Y/Y)
Common stock, 0.0001
par value...
$2,346
(40.23%↑ Y/Y)
Deferred collaboration
revenue
$1,233,452
(68.72%↑ Y/Y)
Accrued expenses
$1,193,460
(-57.96%↓ Y/Y)
Accounts payable
$1,085,519
(16.55%↑ Y/Y)
Back
Back
Balance Sheet
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)
source: myfinsight.com